← back to search

Ning Zhao

National Patient Safety Foundation · CN
Area of research
Materials Chemistry · Surgery
Research interest
Research interests include Crystallization and Solubility Studies, X-ray Diffraction in Crystallography, Bladder and Urothelial Cancer Treatments, and Crystallography and molecular interactions.
h-index
24
citations
1,892
works
315
NIH funding
primary concept
Chemistry
email

Recent publications

Clathrin Light Chain B Drives Hepatocellular Carcinoma Progression Through Dual Mechanisms: Small Extracellular Vesicle‐Mediated Angiogenesis and the NF‐κB–PCLAF Signaling Axis
Advanced Science 2025cited by 2position: middledoi
LncRNA HMOX1 alleviates renal ischemia-reperfusion-induced ferroptotic injury via the miR-3587/HMOX1 axis
Cellular Signalling 2024cited by 8position: middledoi
Caulerpa chemnitzia polysaccharide exerts immunomodulatory activity in macrophages by mediating the succinate/PHD2/HIF-1α/IL-1β pathway
International Journal of Biological Macromolecules 2024cited by 8position: middledoi
RNA-seq shows Angiopoietin-like 4 promotes hepatocellular carcinoma progression by inducing M2 polarization of tumor-associated macrophages
International Journal of Biological Macromolecules 2024cited by 2position: middledoi
Synthesis and evaluation of indole-containing derivatives as C-linked PD-L1 inhibitors for cancer immunotherapy
Journal of Molecular Structure 2023cited by 5position: middledoi
Puerarin Induces Molecular Details of Ferroptosis-Associated Anti-Inflammatory on RAW264.7 Macrophages
Metabolites 2022cited by 26position: middledoi
Anti-Colon Cancer Activity of Dietary Phytochemical Soyasaponin I and the Induction of Metabolic Shifts in HCT116
Molecules 2022cited by 15position: middledoi
The Role of ANGPTL Gene Family Members in Hepatocellular Carcinoma
Disease Markers 2022cited by 12position: middledoi
In Vivo Measurement of Granzyme Proteolysis from Activated Immune Cells with PET
ACS Central Science 2021cited by 59position: firstdoi
PD-L1 Protein Expression and Gene Amplification Correlate with the Clinicopathological Characteristics and Prognosis of Lung Squamous Cell Carcinoma
Cancer Management and Research 2021cited by 6position: middledoi
Ferronostics: Measuring Tumoral Ferrous Iron with PET to Predict Sensitivity to Iron-Targeted Cancer Therapies
Journal of Nuclear Medicine 2020cited by 55position: firstdoi
Molecular Imaging of Prostate Cancer Targeting CD46 Using ImmunoPET
Clinical Cancer Research 2020cited by 40position: middledoi
Reversal effects of milbemycins on multidrug resistance in MCF-7/adr cells
Zhongguo yaolixue tongbao 2013cited by 0position: lastdoi

Grants

No grants ingested yet.

Frequent collaborators

Yang Yu · Shandong University3 papers (2022–2025)Xiaoke Sun · Harbin Medical University3 papers (2022–2025)Yung-Hua Wang · Gladstone Institutes3 papers (2020–2021)Yangjie Huang · Minjiang University3 papers (2020–2021)Guanghua Cui · Harbin Medical University3 papers (2022–2025)Yun Bai · Kunming University of Science and Technology3 papers (2022–2025)Jinzi Zeng · South China Agricultural University3 papers (2022–2024)Michael J. Evans · UCSF Helen Diller Family Comprehensive Cancer Center3 papers (2020–2021)Riming Huang · California Institute of Technology3 papers (2022–2024)Xuewei Xia · South China Agricultural University2 papers (2022–2022)Di Qu · Harbin Medical University2 papers (2022–2024)Youngho Seo · University of California, San Francisco2 papers (2020–2020)Meijuan Ding · Harbin Medical University2 papers (2024–2025)Jiajia Yang · Zhejiang Chinese Medical University2 papers (2022–2022)Zhiyuan Liu · South China Agricultural University2 papers (2022–2022)Bin Liu · Suizhou Central Hospital1 papers (2020–2020)Boya Xiao · South China Agricultural University1 papers (2023–2023)Rui Xiao · Nanchang University1 papers (2024–2024)Hui‐Wen Wu · National University of Singapore1 papers (2021–2021)Yirong Xu · Ministry of Education1 papers (2021–2021)